Medical Electrical Stimulation Market is Expected to Reach $7,367.5 Million by 2026

ABOUT THIS REPORT

OVERVIEW

Medical Electrical Stimulation Market is valued at USD XX million in 2019 and is expected to reach USD 7,367.5 million by the end of 2026.

Bizlytikanalysts forecast the global Medical Electrical Stimulation market to grow at a CAGR of 6.3% during the forecast period, according to their latest market research report.

Electrical stimulation device transmits electrical current to muscles to make them contract. Electrical stimulation helps to treat muscular contraction as a result of wounds or neurological ailments. There are various type of electrical stimulation device including Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices and more.

According to the World Health Organization (WHO), neurodegenerative diseases affect approximately 30 million individuals worldwide. According to the Alzheimer’s Association, in 2019, around 50 million people had Alzheimer’s or related dementia globally. In 2019, more than 5 million Americans of all ages had Alzheimer’s, and the number will rise by nearly 14 million by 2050. According to Harvard NeuroDiscovery Center, in 2019, around 1 million Americans have Parkinson’s, 400,000 from multiple sclerosis, 30,000 from amyotrophic lateral sclerosis, and 30,000 from Huntington’s disease. So, the rising incidence of neurodegenerative disorders is boosting the global Medical Electrical Stimulation market. The regulatory bodies are conducting research programs for the awareness of Neurodegenerative Disorders. For instance, Health Europa has conducted a Joint Programme on Neurodegenerative Disease Research (JPND) across 30 countries. The JPND aimed to discover better cures, treatments and diagnostic tools for neurodegenerative diseases. The companies are directing conferences to spread awareness among people about Neurodegenerative Disorders is improving market growth. For instance, there are numerous neurodegenerative disorder conferences held around the world in 2020 to spread awareness, such as International Conference on Neurology & Neurophysiology, World Congress on Vascular Dementia and Neurodegenerative Diseases, and many more.

Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation (DBS) Devices, Vagus Nerve Stimulation (VNS) Devices, Sacral Nerve Stimulation (SNS) Devices, Gastric Electric Stimulation (GES) Devices, Transcutaneous electrical nerve stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices and Others are covered in the Type segment of the market scope, the Application segment is categorized into pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management and Others. The report covers value of the global market by Type and Application.

The market value of Spinal Cord Stimulation (SCS) Devices was USD XX Million in 2019, and it is expected to reach USD XX Million by 2026, growing at a CAGR of 6.3%during 2020-2026. The increase in development of new Spinal Cord Stimulation (SCS) system and competitive advancement to increase product portfolio and revenue would propel the growth of the segment.

North America, Europe, AsiaPacific, South America, and Middle East & Africa are taken into consideration at the global Medical Electrical StimulationValue figures. While North America is further categorized into enhancing United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involvingGCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North AmericaMedical Electrical Stimulationmarketwas USD XX Million in 2019, and it is predicted to reach USD XX Million by 2026, growing at a CAGR of 6.4%during the forecast period. The commercialization of new products, regulatory approval of products and strategic partnership between companies to expand their business around the globe would improve the growth prospects of the market.
Major players operating in the Medical Electrical Stimulation industry include Medtronic, Boston Scientific Corporation, Abbott, Livanova, Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Biocontrol Medical, Synapse Biomedical, Neuronetics.

Formation of strategic collaborations and commercialization of products are the few business strategies adopted by the key companies, with a focus on maintaining a competitive advantage over others, and development of advanced medical electrical stimulation device is boosting the market growth.